Infectious Disease & Vaccines
Part of Biotech - Drug Development
 MRK | Merck & Co., Inc. | $315.6b | $152.78 | -2.1% | 7.1M |
 GILD | Gilead Sciences Inc | $161.7b | $147.40 | -0.4% | 3.1M |
 PFE | Pfizer Inc. | $142.7b | $28.28 | -1.0% | 27.3M |
 MRNA | Moderna, Inc. Common Stock | $22.0b | $147.66 | -5.7% | 21.0M |
 SMMT | Summit Therapeutics Inc. Common Stock | $10.4b | $14.27 | +6.4% | 10.8M |
 PCVX | Vaxcyte, Inc. Common Stock | $7.7b | $61.09 | -0.1% | 749.0K |
 BCRX | BioCryst Pharmaceuticals Inc | $2.3b | $9.79 | -0.1% | 1.4M |
 VIR | Vir Biotechnology, Inc. Common Stock | $1.5b | $10.90 | +3.6% | 1.9M |
 NVAX | Novavax Inc | $1.2b | $9.22 | -2.4% | 3.2M |
 ABUS | Arbutus Biopharma Corporation Common Stock | $0.9b | $5.21 | -0.2% | 4.4M |
 CRMD | CorMedix Inc. | $0.6b | $8.38 | -2.2% | 726.2K |
 ASMB | Assembly Biosciences, Inc | $497.6m | $35.42 | +0.0% | 149.1K |
 AVIR | Atea Pharmaceuticals, Inc. Common Stock | $376.1m | $5.51 | +1.7% | 192.6K |
 EBS | Emergent Biosolutions, Inc. | $372.5m | $5.99 | +5.9% | 1.0M |
 ENTA | Enanta Pharmaceuticals, Inc | $366.4m | $14.13 | +0.5% | 134.8K |
 SIGA | SIGA Technologies Inc. | $230.2m | $3.07 | +1.3% | 591.0K |
 ANTX | AN2 Therapeutics, Inc. Common Stock | $192.7m | $5.39 | -2.7% | 273.4K |
 TNXP | Tonix Pharmaceuticals Holding Corp. | $170.0m | $13.61 | -0.1% | 490.0K |
 ARMP | Armata Pharmaceuticals, Inc. Common Stock | $166.7m | $5.42 | -2.0% | 54.7K |
 ARCT | Arcturus Therapeutics Holdings Inc. Common Stock | $163.7m | $15.50 | +2.6% | 2.2M |
 IVVD | Invivyd, Inc. Common Stock | $157.6m | $0.92 | -3.6% | 3.6M |
 ZTEK | Zentek Ltd. Common Stock | $85.3m | $0.57 | 0.0% | 34.9K |
 XBIT | XBiotech Inc | $68.1m | $2.30 | 0.0% | 21.1K |
 SPRO | Spero Therapeutics, Inc. Common Stock | $66.6m | $1.22 | -1.6% | 146.7K |
 INO | Inovio Pharmaceuticals, Inc. | $55.7m | $1.28 | +1.2% | 3.7M |
 SCYX | SCYNEXIS, Inc. | $50.3m | $5.92 | +9.7% | 216.3K |
 MCRB | Seres Therapeutics, Inc. | $48.7m | $4.75 | -5.1% | 56.1K |
 IBO | Impact BioMedical, Inc. | $46.4m | $0.46 | -4.4% | 11.7K |
 NNVC | NanoViricides Inc. | $39.5m | $1.26 | -1.6% | 178.0K |
 TVGN | Tevogen Inc. Common Stock | $29.6m | $6.63 | 0.0% | 1.6K |
 ALGS | Aligos Therapeutics, Inc. Common Stock | $26.2m | $7.82 | -0.8% | 66.0K |
 PLRZ | Polyrizon Ltd. Ordinary Shares | $22.1m | $11.35 | +1.7% | 41.6K |
 ATOS | Atossa Therapeutics, Inc. Common Stock | $20.6m | $2.64 | 0.0% | 26.1K |
 COCP | Cocrystal Pharma, Inc. Common Stock | $11.3m | $1.13 | -0.9% | 18.6K |
 TRAW | Traws Pharma, Inc. Common Stock | $7.2m | $0.61 | +4.4% | 173.7K |
 AIM | AIM ImmunoTech Inc. | $7.0m | $0.25 | +0.1% | 370.1K |
 IMNN | Imunon, Inc. Common Stock | $6.7m | $1.60 | -2.1% | 47.6K |
 APM | Aptorum Group Limited Class A Ordinary Shares | $6.4m | $0.80 | 0.0% | N/A |
 ACXP | Acurx Pharmaceuticals, Inc. Common Stock | $6.2m | $1.45 | +2.5% | 145.2K |
 XBIO | Xenetic Biosciences, Inc. | $6.1m | $3.73 | +0.7% | 21.9K |
 SNGX | Soligenix, Inc. Common Stock | $5.6m | $0.39 | -4.8% | 590.2K |
 CODX | Co-Diagnostics, Inc. Common Stock | $5.3m | $1.27 | +2.4% | 73.4K |
 ITRM | Iterum Therapeutics plc Ordinary Share | $3.8m | $0.03 | +5.0% | 43.6M |
 GOVX | GeoVax Labs, Inc. New | $3.5m | $0.63 | -2.3% | 270.7K |
 SXTP | 60 Degrees Pharmaceuticals, Inc. Common Stock | $3.1m | $1.06 | -4.9% | 94.0K |
 MBRX | Moleculin Biotech, Inc. | $3.0m | $0.61 | -0.2% | 452.1K |
 SBFM | Sunshine Biopharma Inc. | $2.8m | $1.23 | +9.6% | 9.2M |
 VRAX | Virax Biolabs Group Limited Ordinary Shares | $2.3m | $2.77 | 0.0% | 89.7K |
 PHGE | BiomX Inc. | $2.0m | $0.13 | -2.7% | 838.4K |
 AEMD | AETHLON MEDICAL INC | $1.7m | $2.27 | -4.8% | 27.7K |